Physician profile
Betsy J Cooper
NPI 1528199346
$2,016.60
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,442 · 2020: $490 · 2021: $85.09.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $649.87 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $305.65 | 2019 | |
| Bausch Health US, LLC | $302.14 | 2019-2021 | |
| Alkermes, INC. | $218.64 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $188.83 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $160.01 | 2019-2020 | |
| Lundbeck LLC | $104.95 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $29.35 | 2019 | |
| Adlon Therapeutics L.P. | $20.40 | 2019 | |
| Avanir Pharmaceuticals, INC. | $20.31 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.45 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.